Ekim Ekinci

4PUBLICATIONS
4CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Climatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 24, 2021
Switching from Biologic to Biosimilar Products: Insight from an Integrated Health Care System.

Bharati Bhardwaja, Shilpa Klocke, Ekim Ekinci

|Jan 05, 2019
Neratinib in HER2-Positive Breast Cancer Patients.

Rutugandha Paranjpe, Dima Basatneh, Gabriel Tao

|Dec 08, 2018
Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients.

Kaitlin Rascon, Goran Flajc, Carmine De Angelis

|Aug 09, 2018
Voriconazole photosensitivity causes apparent graft-versus-host disease exacerbation.

Akash Mukherjee, Ekim Ekinci, Audrey Scholoff

Pageof 1